ARTICLE | Clinical News
Buprenorphine: Phase I started
June 1, 2015 7:00 AM UTC
Relmada began a crossover, Canadian Phase I trial to compare single doses of oral REL-1028 vs. marketed IV and sublingual formulations of buprenorphine in 30 healthy volunteers. The company is develop...